Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Open Label Extension In Cancer Patients

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: January 26, 2009
Last updated: March 3, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 3, 2014